Company / Operating Cash Flow
CHAMPIONS ONCOLOGY, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$6.1M
FY2025
5-year range
-$6.1M / $7.4M
FY2021-FY2025
Trend
-183.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has fluctuated over the past 10 years, ranging from -$10M in FY2016 to $7M in FY2024.
Based on SEC 10-K filings.
-$6M in FY2025.
Declined from $6M to -$6M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow decreased 183.1% year-over-year.
- Peak operating cash flow was recorded in FY2024.
- Lowest operating cash flow in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.1M | -183.1% |
| FY2024 | $7.4M | +13.7% |
| FY2023 | $6.5M | +486.5% |
| FY2022 | -$1.7M | -157.9% |
| FY2021 | $2.9M | +272.8% |
| FY2020 | -$1.7M | -157.9% |
| FY2019 | $2.9M | +202.3% |
| FY2018 | -$2.8M | +55.7% |
| FY2017 | -$6.4M | +33.5% |
| FY2016 | -$9.6M | -180.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026